Sydney, Australia – NuSep (ASX: NSP) is pleased to advise the market that it has appointed BioExpress Inc to distribute the Company’s Gels in the US.

BioExpress is a leading US distributor of equipment, consumables, reagents and lab essentials into the US life science research marketplace. They have over 35 Molecular Biology trained sales people selling nationwide. BioExpress is also the preferred supplier to several US academic institutions, which opens up a number of new markets for NuSep.

The NuSep Gels complement BioExpress’ existing product range enabling BioExpress to complete its electrophoresis product offering. BioExpress will launch the Gels this month.

This new expanded distribution agreement will significantly expand NuSep’s access to the key US market. The Company anticipates that BioExpress will generate more than $250,000 of gels sales to NuSep in the first full year. NuSep estimates that the US Analytical Gel market is worth $60m pa.

Dr Hari Nair, Managing Director of NuSep said that “This is a significant achievement for NuSep as it strengthens our relationship with one of the premier Life Science companies in the US and broadens the reach for our Gel products. We look forward to a long and mutually beneficial business partnership with BioExpress”.

Mr John Manusu, NuSep’s Executive Chairman said, “The BioExpress appointment further strengthens our distribution network and is a significant step towards our goal to achieve a 10% market share of the Gels market”.

Randy Scott, President/CEO of BioExpress said that “We are pleased to distribute the NuSep Gels, as they compliment our product offering perfectly and expect these products to generate significant sales for us over the coming years”.